Anemia increases risk of death in the very elderly

Jul 27, 2009

Anemia in very elderly people aged 85 and older appears to be associated with an increased risk of death, according to a new study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/press/cmaj090040.pdf.

The study was part of the Leiden 85-plus study that looked at 562 people aged 85 years in the Netherlands and followed them until age 90. Twenty-seven per cent of participants had anemia at the start of the study (prevalent anemia) and, in the follow up period, incident anemia developed in 24% of the people without anemia at the start of the study.

Anemia in elderly people is generally associated with increased as well as decreased mobility, cognitive impairment, depression, falls and fractures, hospital admission and diminished quality of life. It can significantly affect health care needs and costs in ageing Western societies.

In the study group, the risk of death was similar among men and women, and among people in long-term care facilities and in the community.

"We found a strong, independent association between prevalent anemia in participants at age 85 years and risk of death," write Ms. Wendy den Elzen of the Leiden University Medical Center and coauthors, confirming results of previous studies of people in the Netherlands and North America. "We found that incident anemia in participants beyond the age of 85 years had an even stronger impact on mortality than prevalent anemia at age 85."

After adjusting for other illnesses, the negative effect of anemia on cognitive ability and physical function was neutralized. The authors conclude that the associated functional decline appears to be mainly attributed to comorbid illnesses.

In a related commentary http://www.cmaj.ca/press/cmaj091199.pdf, Dr. Mark Clarfield of Ben-Gurion University and Dr. Ora Paltiel of Hadassah-Hebrew University in Israel write "for unexplained anemia in elderly patients, we may never be able to disentangle whether the underlying cause or the anemia is responsible for death." They caution that proof is needed that routinely correcting unexplained is more beneficial than harmful.

Source: (news : web)

Explore further: Research shows that bacteria survive longer in contact lens cleaning solution than thought

add to favorites email to friend print save as pdf

Related Stories

Proton pump inhibitors increase risk of bone fractures

Aug 12, 2008

Patients who use proton pump inhibitors for 7 or more years to treat reflux, peptic ulcers and other conditions are at greater risk of osteoporosis-related fractures, according to this large observational study of 15,792 ...

Women may stop anticoagulants after blood clots

Aug 25, 2008

Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor, concludes a study of 646 participants ...

Recommended for you

Ebola virus in Africa outbreak is a new strain

13 hours ago

The Ebola virus that has killed scores of people in Guinea this year is a new strain—evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.

Researchers see hospitalization records as additional tool

13 hours ago

Comparing hospitalization records with data reported to local boards of health presents a more accurate way to monitor how well communities track disease outbreaks, according to a paper published April 16 in the journal PLOS ON ...

User comments : 0

More news stories

Firm targets 3D printing synthetic tissues, organs

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

Survival hope for melanoma patients thanks to new vaccine

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Biologists help solve fungi mysteries

(Phys.org) —A new genetic analysis revealing the previously unknown biodiversity and distribution of thousands of fungi in North America might also reveal a previously underappreciated contributor to climate ...

Robotics goes micro-scale

(Phys.org) —The development of light-driven 'micro-robots' that can autonomously investigate and manipulate the nano-scale environment in a microscope comes a step closer, thanks to new research from the ...